Research field (2)：
Urology
, Medical biochemistry
Research keywords (3)：
腎尿路生殖器
, 腫瘍学
, Urologic Oncology
Research theme for competitive and other funds (2)：
2002 - Molecalav Approach of Urologic Oncology
泌尿器腫瘍に対する分子生物学的研究
MISC (6)：
Connexin 26 Enhanced the Bystander Effect in HSVtk/GCD Gene Therapy for Human Bladder Cancer by Adenovirus /PLL/DNA Gene Delivery. Gene Therapy. 2001. 8, 139-148
Connexin 26 Gene Therapy of Human Bladder Cancer: Induction of Growth Suppression, Apoptosis, and Synagy with Cisplatin. Human Gene therapy. 2001. 12, 2225-2236
Connexin 26 Enhanced the Bystander Effect in HSVtk/GCD Gene Therapy for Human Bladder Cancer by Adenovirus /PLL/DNA Gene Delivery. Gene Therapy. 2001. 8, 139-148
Connexin 26 Gene Therapy of Human Bladder Cancer: Induction of Growth Suppression, Apoptosis, and Synagy with Cisplatin. Human Gene therapy. 2001. 12, 2225-2236
